{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:58:16Z","timestamp":1762340296509},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11,1]]},"DOI":"10.2146\/news090080","type":"journal-article","created":{"date-parts":[[2009,10,22]],"date-time":"2009-10-22T17:30:06Z","timestamp":1256232606000},"page":"1890-1890","source":"Crossref","is-referenced-by-count":20,"title":["FDA approves pralatrexate for treatment of rare lymphoma"],"prefix":"10.1093","volume":"66","author":[{"given":"Cheryl A.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/66\/21\/1890\/28314705\/ajhp1890.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T06:50:50Z","timestamp":1554879050000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/66\/21\/1890\/5130420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,1]]},"references-count":0,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2009,11,1]]}},"URL":"https:\/\/doi.org\/10.2146\/news090080","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,11,1]]},"published":{"date-parts":[[2009,11,1]]}}}